Junbin Ding

493 total citations
14 papers, 346 citations indexed

About

Junbin Ding is a scholar working on Cancer Research, Molecular Biology and Genetics. According to data from OpenAlex, Junbin Ding has authored 14 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 10 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Junbin Ding's work include Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (5 papers) and RNA modifications and cancer (3 papers). Junbin Ding is often cited by papers focused on Cancer-related molecular mechanisms research (9 papers), Circular RNAs in diseases (5 papers) and RNA modifications and cancer (3 papers). Junbin Ding collaborates with scholars based in China. Junbin Ding's co-authors include Weiyan Liu, Anwei Mao, Jingfeng Lu, Jiazhe Liu, Jindong Li, Xiang Zhou, Hongchang Li, Yanxia Liu, Cheng Qian and Zhen Yang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Cellular and Molecular Medicine and Cancer Biology & Therapy.

In The Last Decade

Junbin Ding

13 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junbin Ding China 10 306 260 34 31 16 14 346
Changshui Zhuang China 11 358 1.2× 215 0.8× 34 1.0× 39 1.3× 23 1.4× 12 396
HUIXING PAN China 11 230 0.8× 206 0.8× 32 0.9× 29 0.9× 25 1.6× 15 286
Yuanting Gu China 12 322 1.1× 292 1.1× 56 1.6× 27 0.9× 27 1.7× 19 394
Zahra Saadatian Iran 13 231 0.8× 218 0.8× 27 0.8× 16 0.5× 25 1.6× 29 312
Z. Ren China 1 386 1.3× 404 1.6× 55 1.6× 19 0.6× 23 1.4× 3 472
Haotian Xu China 10 288 0.9× 233 0.9× 45 1.3× 52 1.7× 14 0.9× 25 372
Denis R. Morais Brazil 12 329 1.1× 327 1.3× 57 1.7× 78 2.5× 27 1.7× 18 429
Chengzhou Lv China 9 213 0.7× 147 0.6× 30 0.9× 26 0.8× 48 3.0× 18 304

Countries citing papers authored by Junbin Ding

Since Specialization
Citations

This map shows the geographic impact of Junbin Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbin Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbin Ding more than expected).

Fields of papers citing papers by Junbin Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junbin Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbin Ding. The network helps show where Junbin Ding may publish in the future.

Co-authorship network of co-authors of Junbin Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Junbin Ding. A scholar is included among the top collaborators of Junbin Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junbin Ding. Junbin Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Lu, Jingfeng, Zhiqiu Hu, Mengxuan Yang, et al.. (2021). Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 Cells. Clinical Breast Cancer. 22(2). e173–e183. 13 indexed citations
3.
Li, Hongchang, Limin Liu, Junbin Ding, et al.. (2021). Astragalus IV Undermines Multi-Drug Resistance and Glycolysis of MDA-MB-231/ADR Cell Line by Depressing hsa_circ_0001982-miR-206/miR-613 Axis. Cancer Management and Research. Volume 13. 5821–5833. 12 indexed citations
4.
Li, Hongchang, Wen Xu, Weiyan Liu, et al.. (2021). Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206/613-led PI3K/Akt/mTOR signaling. Aging. 13(3). 4522–4551. 66 indexed citations
5.
6.
Ding, Junbin, et al.. (2020). Long Noncoding RNA FBXL19-AS1 Expedites Cell Growth, Migration and Invasion in Cervical Cancer by miR-193a-5p/PIN1 Signaling. SHILAP Revista de lepidopterología.
7.
Ding, Junbin, et al.. (2020). LncRNA FLVCR1-AS1 promotes proliferation, migration and activates Wnt/β-catenin pathway through miR-381-3p/CTNNB1 axis in breast cancer. Cancer Cell International. 20(1). 214–214. 22 indexed citations
8.
Mao, Anwei, et al.. (2020). Circular RNA hsa_circ_0061825 (circ‐TFF1) contributes to breast cancer progression through targeting miR‐326/TFF1 signalling. Cell Proliferation. 53(2). e12720–e12720. 100 indexed citations
9.
Li, Hongchang, Jiazhe Liu, Weiyan Liu, et al.. (2020). Hypermethylation of lncRNA MEG3 impairs chemosensitivity of breast cancer cells. Journal of Clinical Laboratory Analysis. 34(9). e23369–e23369. 19 indexed citations
10.
Mao, Anwei, et al.. (2019). KLF8 is associated with poor prognosis and regulates glycolysis by targeting GLUT4 in gastric cancer. Journal of Cellular and Molecular Medicine. 23(8). 5087–5097. 52 indexed citations
11.
Ding, Junbin, et al.. (2019). FOXF2 aggravates the progression of non-small cell lung cancer through targeting lncRNA H19 to downregulate PTEN.. European review for medical and pharmacological sciences. 23(24). 10796–10802. 20 indexed citations
12.
Lu, Jingfeng, et al.. (2018). Clinical significance of prognostic score based on age, tumor size, and grade in gastric cancer after gastrectomy. Cancer Management and Research. Volume 10. 4279–4286. 7 indexed citations
13.
Mao, Anwei, et al.. (2018). KLF8 is Associated with Poor Prognosis and Regulates Glycolysis by Targeting GLUT4 in Gastric Cancer. SSRN Electronic Journal. 3 indexed citations
14.
Shi, Rong‐Liang, et al.. (2016). Expression and significance of VEGF and HIF-1 in papillary thyroid carcinoma.. 16(11). 1368–1374. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changshui Zhuang Breakdown of academic impact, for papers by HUIXING PAN Breakdown of academic impact, for papers by Yuanting Gu Breakdown of academic impact, for papers by Zahra Saadatian Breakdown of academic impact, for papers by Z. Ren Breakdown of academic impact, for papers by Haotian Xu Breakdown of academic impact, for papers by Denis R. Morais Breakdown of academic impact, for papers by Chengzhou Lv
Rankless by CCL
2026